We are live on ! Find out more
PP

Paloma Partners Portfolio holdings

AUM $510M
1-Year Est. Return 286.05%
This Fund
S&P 500
This Quarter Est. Return
+3.59%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$10.2B
AUM Growth
+$2.21B
Cap. Flow
+$1.91B
Cap. Flow %
18.7%
Top 10 Hldgs %
42.15%
Holding
2,326
New
523
Increased
761
Reduced
552
Closed
381

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$88.6M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$55.2M
3
AMZN icon
Amazon
AMZN
+$50.7M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$50.4M
5
AAPL icon
Apple
AAPL
+$27.4M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 4.46%
2 Industrials 3.74%
3 Financials 3.69%
4 Healthcare 3.55%
5 Technology 3.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVZ icon
551
Invesco
IVZ
$13.3B
$2.41M 0.02%
79,539
+64,095
+415% +$1.97M
TKR icon
552
Timken Company
TKR
$9.81B
$2.41M 0.02%
60,649
+5,696
+10% +$212K
DRH icon
553
Diamondrock Hospitality Co
DRH
$2.64B
$2.4M 0.02%
208,533
+100,891
+94% +$1.02M
GEN icon
554
Gen Digital
GEN
$16.1B
$2.4M 0.02%
100,332
+61,148
+156% +$1.5M
MHK icon
555
CALL
Mohawk Industries
MHK
$7.05B
$2.4M 0.02%
12,000
-6,000
-33% -$1.18M
MHK icon
556
PUT
Mohawk Industries
MHK
$7.05B
$2.4M 0.02%
12,000
-6,000
-33% -$1.18M
ORLY icon
557
CALL
O'Reilly Automotive
ORLY
$75.1B
$2.39M 0.02%
129,000
+81,000
+169% +$1.48M
BMRN icon
558
BioMarin Pharmaceuticals
BMRN
$11.6B
$2.39M 0.02%
28,846
+6,251
+28% +$538K
BUD icon
559
AB InBev
BUD
$156B
$2.39M 0.02%
22,642
+16,091
+246% +$1.8M
FLR icon
560
CALL
Fluor
FLR
$7.22B
$2.38M 0.02%
+45,400
New +$2.36M
IYR icon
561
CALL
iShares US Real Estate ETF
IYR
$4.73B
$2.38M 0.02%
30,900
+10,900
+55% +$828K
ABT icon
562
Abbott
ABT
$182B
$2.38M 0.02%
61,855
+37,887
+158% +$1.5M
EBAY icon
563
CALL
eBay
EBAY
$50.3B
$2.38M 0.02%
80,000
-40,000
-33% -$1.18M
SYY icon
564
Sysco
SYY
$40.2B
$2.38M 0.02%
42,885
+8,747
+26% +$454K
ALL icon
565
CALL
Allstate
ALL
$67.3B
$2.37M 0.02%
+32,000
New +$2.25M
ALL icon
566
PUT
Allstate
ALL
$67.3B
$2.37M 0.02%
+32,000
New +$2.25M
OVV icon
567
Ovintiv
OVV
$16.6B
$2.37M 0.02%
40,300
+26,865
+200% +$1.53M
CHKP icon
568
CALL
Check Point Software Technologies
CHKP
$13.6B
$2.37M 0.02%
+28,000
New +$2.3M
CHKP icon
569
PUT
Check Point Software Technologies
CHKP
$13.6B
$2.37M 0.02%
+28,000
New +$2.3M
ALSN icon
570
Allison Transmission
ALSN
$10.1B
$2.36M 0.02%
69,939
+30,877
+79% +$961K
CM icon
571
Canadian Imperial Bank of Commerce
CM
$108B
$2.35M 0.02%
57,736
+44,312
+330% +$1.74M
HUN icon
572
Huntsman Corp
HUN
$2.06B
$2.35M 0.02%
123,345
+95,141
+337% +$1.73M
EXC icon
573
Exelon
EXC
$48.2B
$2.35M 0.02%
92,619
-1,185
-1% -$28.1K
VRTX icon
574
Vertex Pharmaceuticals
VRTX
$122B
$2.35M 0.02%
31,833
+21,179
+199% +$1.72M
DCI icon
575
Donaldson
DCI
$10.8B
$2.34M 0.02%
55,682
+10,428
+23% +$414K

Similar funds

Paloma Partners's Q4 2016 Portfolio in Review

As of Q4 2016, Paloma Partners held 2,326 positions worth $10.2B, up 28% from $7.99B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Paloma Partners deployed $1.91B of net new capital in Q4 2016, opening 523 new positions and adding to 761 existing holdings. Its largest new stake was NXP Semiconductors: 253,000 shares worth $24.8M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 4.5% of assets, up from 3.4% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was KLA, an estimated $30.4M trimmed.

  • Paloma Partners's largest Q4 2016 buy was NXP Semiconductors: 253,000 shares worth $24.8M.
  • Paloma Partners added most to Biogen in Q4 2016, an estimated $88.6M increase.
  • Paloma Partners's biggest Q4 2016 reduction was KLA, cutting an estimated $30.4M.
  • Paloma Partners fully exited St Jude Medical in Q4 2016, selling an estimated $13.5M.
  • Paloma Partners's ten largest holdings make up 42% of its $10.2B portfolio in Q4 2016.
  • Paloma Partners opened 523 new positions and closed 381 in Q4 2016.
  • Paloma Partners's portfolio value rose 28% quarter-over-quarter to $10.2B.

Based on Paloma Partners's 13F filing for Q4 2016, filed 14 Feb 2017.